[Retracted] EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P‑gp substrates in vitro and in vivo.
Saved in:
| Title: | [Retracted] EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P‑gp substrates in vitro and in vivo. |
|---|---|
| Authors: | Jin Y; Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200240, P.R. China., Zhang W; Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200240, P.R. China., Wang H; Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200240, P.R. China., Zhang Z; Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200240, P.R. China., Chu C; Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200240, P.R. China., Liu X; Department of Pathology, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai 200240, P.R. China., Zou Q; Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200240, P.R. China. |
| Source: | Oncology reports [Oncol Rep] 2026 Apr; Vol. 55 (4). Date of Electronic Publication: 2026 Feb 06. |
| Publication Type: | Journal Article; Retraction Notice |
| Journal Info: | Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1791-2431 |
|---|---|
| DOI: | 10.3892/or.2026.9066 |
